These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 24107103

  • 21. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
    Yoshimine Y, Uto H, Kumagai K, Mawatari S, Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, Tamai T, Moriuchi A, Tsubouchi H, Ido A.
    Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
    [Abstract] [Full Text] [Related]

  • 22. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534
    [Abstract] [Full Text] [Related]

  • 23. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    Ezquer M, Ezquer F, Ricca M, Allers C, Conget P.
    J Hepatol; 2011 Nov 01; 55(5):1112-20. PubMed ID: 21356258
    [Abstract] [Full Text] [Related]

  • 24. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL.
    Contrast Media Mol Imaging; 2019 Nov 01; 2019():6298128. PubMed ID: 31866798
    [Abstract] [Full Text] [Related]

  • 25. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models.
    Nachit M, De Rudder M, Thissen JP, Schakman O, Bouzin C, Horsmans Y, Vande Velde G, Leclercq IA.
    J Cachexia Sarcopenia Muscle; 2021 Feb 01; 12(1):144-158. PubMed ID: 33244884
    [Abstract] [Full Text] [Related]

  • 26. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S, Panera N, Mina M, Gnani D, De Stefanis C, Crudele A, Rychlicki C, Petrini S, Bruscalupi G, Agostinelli L, Stronati L, Cucchiara S, Musso G, Furlanello C, Svegliati-Baroni G, Nobili V, Alisi A.
    Oncotarget; 2015 Dec 08; 6(39):41434-52. PubMed ID: 26573228
    [Abstract] [Full Text] [Related]

  • 27. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M, Csak T, Szabo G.
    World J Gastroenterol; 2014 Jul 14; 20(26):8525-34. PubMed ID: 25024607
    [Abstract] [Full Text] [Related]

  • 28. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE, Fu PP, Kumar P, Smith T, Karpen SJ, Anania FA.
    J Nutr Biochem; 2015 Mar 14; 26(3):285-92. PubMed ID: 25577467
    [Abstract] [Full Text] [Related]

  • 29. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y, Nagashimada M, Zhan L, Nagata N, Kobori M, Sugiura M, Ogawa K, Kaneko S, Ota T.
    Endocrinology; 2015 Mar 14; 156(3):987-99. PubMed ID: 25562616
    [Abstract] [Full Text] [Related]

  • 30. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S, Souza-Mello V, Magliano DC, Marinho Tde S, Aguila MB, Mandarim-de-Lacerda CA.
    Life Sci; 2015 Apr 15; 127():73-81. PubMed ID: 25748419
    [Abstract] [Full Text] [Related]

  • 31. Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH.
    De Rudder M, Bouzin C, Nachit M, Louvegny H, Vande Velde G, Julé Y, Leclercq IA.
    Lab Invest; 2020 Jan 15; 100(1):147-160. PubMed ID: 31506634
    [Abstract] [Full Text] [Related]

  • 32. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F.
    Clin Exp Pharmacol Physiol; 2013 Jul 15; 40(7):422-30. PubMed ID: 23611112
    [Abstract] [Full Text] [Related]

  • 33. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 15; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 34. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD, Kong B, Pan Y, Zhan L, Sun R, Aa J, Rizzolo D, Richardson JR, Chen A, Goedken M, Aleksunes LM, Laskin DL, Guo GL.
    Toxicol Appl Pharmacol; 2017 Sep 01; 330():1-8. PubMed ID: 28673684
    [Abstract] [Full Text] [Related]

  • 35. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH, Skat-Rørdam J, Tsamouri MM, Latta M, Lykkesfeldt J, Tveden-Nyborg P.
    Mol Genet Genomics; 2019 Jun 01; 294(3):649-661. PubMed ID: 30759275
    [Abstract] [Full Text] [Related]

  • 36. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M, Cansby E, Nuñez-Durán E, Pirazzi C, Ståhlman M, Stenfeldt E, Smith U, Borén J, Mahlapuu M.
    FASEB J; 2015 Apr 01; 29(4):1564-76. PubMed ID: 25609431
    [Abstract] [Full Text] [Related]

  • 37. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, Shao F, Wu K, Liang J.
    J Hepatol; 2018 Apr 01; 68(4):773-782. PubMed ID: 29273476
    [Abstract] [Full Text] [Related]

  • 38. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW, Gorrell MD, Yue DK, Twigg SM.
    J Hepatol; 2011 Aug 01; 55(2):435-44. PubMed ID: 21184785
    [Abstract] [Full Text] [Related]

  • 39. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y.
    Metabolism; 2017 Apr 01; 69():177-187. PubMed ID: 28285648
    [Abstract] [Full Text] [Related]

  • 40. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M, Hashimoto K, Ishikawa T, Miyamoto Y.
    Int J Exp Pathol; 2019 Apr 01; 100(2):72-82. PubMed ID: 30887659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.